Bicycle Therapeutics PLC (BCYC)
20.54
+0.28
(+1.38%)
USD |
NASDAQ |
Nov 22, 16:00
20.57
+0.03
(+0.15%)
After-Hours: 20:00
Bicycle Therapeutics Cash from Operations (Quarterly): -39.83M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -39.83M |
| June 30, 2024 | -44.63M |
| March 31, 2024 | -70.87M |
| December 31, 2023 | -47.29M |
| September 30, 2023 | -1.025M |
| June 30, 2023 | 34.10M |
| March 31, 2023 | -46.41M |
| December 31, 2022 | -30.31M |
| September 30, 2022 | -5.871M |
| June 30, 2022 | -23.53M |
| March 31, 2022 | -26.40M |
| December 31, 2021 | -10.44M |
| September 30, 2021 | 21.72M |
| June 30, 2021 | -12.37M |
| Date | Value |
|---|---|
| March 31, 2021 | -13.71M |
| December 31, 2020 | -16.62M |
| September 30, 2020 | -9.985M |
| June 30, 2020 | -12.35M |
| March 31, 2020 | 21.16M |
| December 31, 2019 | -4.919M |
| September 30, 2019 | -10.88M |
| June 30, 2019 | -7.608M |
| March 31, 2019 | -5.201M |
| December 31, 2018 | -8.854M |
| September 30, 2018 | -4.658M |
| June 30, 2018 | -5.293M |
| March 31, 2018 | -7.273M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-70.87M
Minimum
Mar 2024
34.10M
Maximum
Jun 2023
-16.98M
Average
-13.04M
Median
Cash from Operations (Quarterly) Benchmarks
| TC BioPharm (Holdings) PLC | -3.055M |
| Adaptimmune Therapeutics PLC | -54.45M |
| NuCana PLC | -1.446M |
| Autolus Therapeutics PLC | -76.74M |
| Biodexa Pharmaceuticals PLC | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.435M |
| Cash from Financing (Quarterly) | -31.93M |
| Free Cash Flow | -203.53M |
| Free Cash Flow Per Share (Quarterly) | -0.5837 |
| Free Cash Flow to Equity (Quarterly) | -9.358M |
| Free Cash Flow to Firm (Quarterly) | -40.27M |
| Free Cash Flow Yield | -19.24% |